Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietin
- 1 October 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 89 (4) , 432-435
- https://doi.org/10.1016/0002-9343(90)90371-j
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Effect of recombinant human erythropoietin on renal function in humansKidney International, 1990
- The Safety and the Efficacy of Maintenance Therapy of Recombinant Human Erythropoietin in Patients With Renal InsufficiencyAmerican Journal of Kidney Diseases, 1989
- Treatment of the Anemia of Progressive Renal Failure with Recombinant Human ErythropoietinNew England Journal of Medicine, 1989
- Recombinant Human Erythropoietin Treatment in Pre-Dialysis PatientsAnnals of Internal Medicine, 1989
- The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietinKidney International, 1989
- Working capacity is increased following recombinant human erythropoietin treatmentKidney International, 1988
- SUBCUTANEOUS ERYTHROPOIETINThe Lancet, 1988
- BLOOD PRESSURE AND ERYTHROPOIETINThe Lancet, 1988
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986